BREAKING: $550M Verdict, Punitives TBD, Smacks Johnson & Johnson in 22-Plaintiff Talc-Cancer Trial

Stock image.  Editor's Note: This is a developing story, and updates will be added as events warrant.  St. Louis—Jurors today slammed Johnson & Johnson with a $550 million verdict, and found punitives potentially warranted, for the role they concluded the company played in the ovarian cancer 22 women developed after years of using its talc-based products. Ingham v. Johnson & Johnson, 1522-CC10417.  

Read more detail on Recent Health Care Law posts –

This entry was posted in Health Law and tagged , , , , , , , , , . Bookmark the permalink.

Leave a Reply